Psoriasis and the new biologic agents: interrupting a T-AP dance
about
Fulfilling an unmet need in psoriasis : do biologicals hold the key to improved tolerability?Efalizumab for the treatment of moderate to severe plaque psoriasis.Efalizumab, a reversible T-cell modulator for psoriasis.Biologic therapeutics in the treatment of psoriasis. Part 1: review.A call for video images: medicine in real time.Enhancement of antibacterial superoxide-anion generation in human monocytes by fumaric acid esters.
P2860
Psoriasis and the new biologic agents: interrupting a T-AP dance
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Psoriasis and the new biologic agents: interrupting a T-AP dance
@ast
Psoriasis and the new biologic agents: interrupting a T-AP dance
@en
type
label
Psoriasis and the new biologic agents: interrupting a T-AP dance
@ast
Psoriasis and the new biologic agents: interrupting a T-AP dance
@en
prefLabel
Psoriasis and the new biologic agents: interrupting a T-AP dance
@ast
Psoriasis and the new biologic agents: interrupting a T-AP dance
@en
P2860
P356
P1476
Psoriasis and the new biologic agents: interrupting a T-AP dance
@en
P2093
Neil H Shear
Scott R A Walsh
P2860
P304
P356
10.1503/CMAJ.1031335
P407
P577
2004-06-01T00:00:00Z